Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/16/1995US5416082 Antiserotonine agents
05/16/1995US5416081 Cephalosporin compounds
05/16/1995US5416080 Cephalosporins
05/16/1995US5416079 21-chloro-pregnane derivative
05/16/1995US5416078 Parenterally administering deferoxamine and a water soluble biopolymer to a human or animal
05/16/1995US5416075 Water, oil, emulsifiers and amphipatic compound
05/16/1995US5416066 1,4-benzothiazepine derivatives
05/16/1995US5416064 Antitumor agents
05/16/1995US5416016 Method for enhancing transmembrane transport of exogenous molecules
05/16/1995US5415875 Anti-peroxide external preparation for skin
05/16/1995US5415873 Anticarcinogenic agents and hormone inhibitors
05/16/1995US5415872 Compositions of gastric acid-resistant microspheres containing salts of bile acids
05/16/1995US5415869 Taxol formulation
05/16/1995US5415867 High ratio active agent: lipid complex
05/16/1995US5415863 Gel contains ethylenediaminetetraacetic acid and carboxypolymethylene; side effect reduction
05/16/1995US5415853 Compressed gas packages using polyoxyethylene glyceryl oleates
05/16/1995US5415695 Method of preparing solid lactulose
05/16/1995CA1335594C Piperidinyl imidazole derivatives as antiarrhythmic agents
05/16/1995CA1335593C Thieno [2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions thereof
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/16/1995CA1335591C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
05/16/1995CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
05/16/1995CA1335588C Antimicrobial superabsorbent compositions and methods
05/16/1995CA1335579C Beta-d-glucan, and its production and uses
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
05/16/1995CA1335573C Dispersible tablets of dihydroergotoxine and of acid addition salts thereof
05/16/1995CA1335572C Derivatives of cyclic amp as treatment for cancer
05/16/1995CA1335570C Silicon compounds in bone treatment
05/16/1995CA1335568C Cosmetic and skin treatment compositions
05/13/1995CA2135536A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof
05/13/1995CA2134192A1 5, 6-bicyclic glycoprotein iib/iiia antagonists
05/12/1995CA2135139A1 Topical antibacterial preparation
05/11/1995WO1995012818A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
05/11/1995WO1995012678A2 Improvements relating to cancer therapy
05/11/1995WO1995012620A1 Derivatized polysaccharide bile acid sequestrant for reducing cholesterol
05/11/1995WO1995012611A1 Endothelin receptor antagonists
05/11/1995WO1995012606A1 5-fluorouracil derivatives
05/11/1995WO1995012603A1 Matrix metalloprotease inhibitors________________________________
05/11/1995WO1995012599A1 Polycyclic antiparasitic agents, process and strain for their preparation and their use
05/11/1995WO1995012598A1 Benzo-fused macrocycles promote release of growth hormone
05/11/1995WO1995012594A1 7H-IMIDAZO(1,2-a)PYRAZINE-8-ONE NMDA RECEPTOR ANTAGONISTS
05/11/1995WO1995012592A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995WO1995012591A1 Phenylindole compounds
05/11/1995WO1995012590A1 Preparation of omeprazole and lansoprazole and intermediates useful therein
05/11/1995WO1995012589A1 Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
05/11/1995WO1995012587A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
05/11/1995WO1995012584A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012578A1 Short-acting dihydropyridines
05/11/1995WO1995012577A1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
05/11/1995WO1995012576A1 New cyclopropyl derivatives, preparation method thereof and applications
05/11/1995WO1995012575A1 (e)-20(22)-dehydrovitamin d compounds
05/11/1995WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/11/1995WO1995012567A1 Total synthesis of taxol and analogues thereof
05/11/1995WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995WO1995012408A1 Plasmin-independent fibrinolysis
05/11/1995WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995WO1995012402A1 Estrogen compositions and method for neuroprotection
05/11/1995WO1995012401A1 Method and means for prevention of cataract
05/11/1995WO1995012400A1 Novel enzyme inhibitors, their synthesis, and methods for use
05/11/1995WO1995012399A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
05/11/1995WO1995012398A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/11/1995WO1995012397A1 Plaster for treating nail mycoses
05/11/1995WO1995012396A1 Method for inhibiting intracellular viral replication
05/11/1995WO1995012395A1 Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012393A1 Plaster for the treatment of nail mycoses
05/11/1995WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation
05/11/1995WO1995012391A1 Gelatin powders with improved tabletability. color and odor characteristics
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012383A1 An injectable solution of testosterone undecanoate
05/11/1995WO1995012378A2 Method and composition for the treatment of neoplasms of the lung and other oncological diseases
05/11/1995WO1995012313A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof
05/11/1995WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
05/11/1995WO1995000638A3 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
05/11/1995DE4421686A1 Liposomes containing bioavailable iron(II) and process for their preparation
05/11/1995DE4337711A1 Compositions which are effective for spotty skin and mild types of acne and which contain monocarboxylic acid monoglycerides of short and medium chain-length fatty acids
05/11/1995CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175838A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995CA2175837A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995CA2175806A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof
05/11/1995CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995CA2175685A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
05/11/1995CA2175667A1 Matrix metalloprotease inhibitors________________________________
05/11/1995CA2175595A1 Method and means for prevention of cataract
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2174548A1 Process for the preparation of n-4-¬(substituted phenyl)alkylthienyl|-, and n-4-¬(substituted phenyl)alkylfuryl|but-3-yn-2-yl|-n-hydroxyurea compounds
05/11/1995CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation
05/11/1995CA2174235A1 Benzo-fused macrocycles promote release of growth hormone
05/11/1995CA2174234A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/11/1995CA2173875A1 Endothelin receptor antagonists
05/11/1995CA2172377A1 Novel 4-piperidinyl substituted lactames as neurokinin 2-receptor antagonists for the treatment of asthma
05/11/1995CA2153146A1 Method for inhibiting intracellular viral replication
05/11/1995CA2152954A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
05/11/1995CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
1 ... 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 7033 7034 7035 7036 7037 7038 7039 ... 7860